USA - July 29 2022
Important developments related to required price reporting to Medicare for clinical laboratories under the Protecting Access to Medicare Act of 2014…
Pat G. Ouellette
USA - July 19 2022
Disclosing known or suspected fraud to regulators can have its benefits. As reported in a previous post, the Department of Justice (DOJ) issued policy…
Jane T. Haviland, Lauren Moldawer
USA - May 5 2022
Last week, the Office of Inspector General (OIG) for the Department of Health and Human Services (HHS) issued Advisory Opinion No. 22-09 (AO 22-09)…
Sarah Beth S. Kuyers
USA - April 14 2022
The Office of Inspector General for the Department of Health and Human Services (OIG) recently published an Advisory Opinion in which it concluded…
Theresa C. Carnegie, Pat G. Ouellette
USA - February 11 2022
In 2021, health care fraud enforcement authorities directed attention to priorities of recent years while increasing their focus on emerging areas…
Grady R. Campion, Brian P. Dunphy, Laurence J. Freedman, Jane T. Haviland, Stephnie A. John, Samantha P. Kingsbury, Laura E. Martin, Kevin M. McGinty